Clinical Trials Logo

Myofascial Pain Syndromes clinical trials

View clinical trials related to Myofascial Pain Syndromes.

Filter by:

NCT ID: NCT05835427 Completed - Fibromyalgia Clinical Trials

The Effect of Stretching and Relaxation Exercises on Anxiety in Individuals With Fibromyalgia

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Fibromyalgia is a non-articular, chronic rheumatic disease of unknown etiology characterized by widespread musculoskeletal pain, sleep disturbance, fatigue, and the presence of multiple tender points.

NCT ID: NCT05826834 Not yet recruiting - Clinical trials for Trigger Point Pain, Myofascial

An Investigation of Ball Rolling Effects on Trigger Points

Start date: July 2023
Phase: N/A
Study type: Interventional

The current study aims to examine the potential effects of rolling a Myostorm ball on the trigger points in the upper back muscles.

NCT ID: NCT05821036 Active, not recruiting - Fibromyalgia Clinical Trials

Examining the Effects of Activity Management in Women With Fibromyalgia Syndrome

Start date: June 27, 2022
Phase: N/A
Study type: Interventional

Purpose: To determine the effects of activity management training on pain, occupational performance, quality of life, depression, anxiety and occupational balance in women with fibromyalgia syndrome (FMS). In addition to, reducing pain, which is the main symptom of FMS, by regulating the activity-rest cycle, it is aimed to increase people's participation in daily life and improve their quality of life. Method: A randomized controlled trial. A total of 10 sessions of individual-internet-based activity management training are applied to women with FMS in the intervention group, 2 sessions a week for 5 weeks, 1st and 10th sessions are pre- and post-training evaluation. Assessments before and after training The Revised Fibromyalgia Impact Questionnaire (FIQR), Canadian Occupational Performance Measure(COPM), Pain-activity patterns scale (Pomp/APPS) ,Nottingham Health Profile,The hospital anxiety and depression scale,The Occupational Balance Questionnaire (OBQ) is applied.Although no intervention is applied to the control group, only preliminary and final evaluations are completed.

NCT ID: NCT05816161 Enrolling by invitation - Clinical trials for Myofascial Trigger Point Pain

Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

to findout the improvement by Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

NCT ID: NCT05815381 Completed - Fibromyalgia Clinical Trials

Autoimmune Mechanisms in Fibromyalgia

FMIgG
Start date: November 16, 2020
Phase:
Study type: Observational

A cohort of fibromyalgia (FM) patients (n =90) and healthy controls (HC) (n= 93) was recruited to investigate the associations between human IgG binding to satellite glia cells (SGC) from dorsal root ganglia (DRG) and pathophysiological mechanisms. The study is based on previously identified mechanisms resulting from injecting human IgG antibodies from FM patients, but not HC, in mice (Goebel et al. J Clin Invest. 2021;131(13):e144201). Subjects have been carefully phenotyped using validated questionnaires and quantitative sensory testing (QST) was applied to determine pain sensitivity. A blood sample was taken to quantify anti-SGC IgG, as well as proteins, lipids and metabolites. Skin biopsies were taken to analyze changes in skin innervation (IENFD) and immune cell activation. Magnetic resonance spectroscopy (MRS) and functional magnetic resonance imaging (fMRI) was performed (n=122) to investigate central nervous system pain related mechanisms. Insular glutamate levels, as well as the levels of other brain metabolites will be determined (MRS) and related to symptom severity and anti-SGC IgG levels. Resting state as well as pain related cerebral activation (BOLD) during standardized evoked pain stimuli will be characterized (fMRI) and related to the MRS findings and to anti-SGC IgG levels.

NCT ID: NCT05807009 Completed - Fibromyalgia Clinical Trials

Role of Core Exercise in Treatment of Fibromyalgia Patients

Start date: December 28, 2022
Phase: N/A
Study type: Interventional

the purpose of this study is to investigate the effect of core exercises on health status, pain, pressure pain thresholds and functional capacity in patients with FM

NCT ID: NCT05801497 Recruiting - Clinical trials for Fibromyalgia, Primary

Balneotherapy in Primary Fibromyalgia

Start date: May 1, 2023
Phase:
Study type: Observational

Balneotherapy (BT) is recommended as non-pharmacological treatment for Fibromyalgia Syndrome (FS). BT efficacy is based on beneficial properties of both mud bath and stay in a spa environment. The main aim of this multicentric prospective longitudinal cohort study is to evaluate BT effectiveness in patients withFS. All FS patients with a stable treatment in the past month and a Fibromyalgia Impact Questionnaire (FIQ) score ≥39 will be enrolled after providing written informed consent. Patients will be divided into two groups based on whether or not BT is added to usual therapy: BT Group and Control Group. Each patients will be assessed at baseline, after 15 and 45 days in BT Group and at baseline and after 15 days in Control group with an assessment of pain by Visual Analogue Scale, FIQ, Short-Form Health Survey, State-Trait Anxiety Inventory (STAI) and Center for Epidemiologic Studies Depression Scale (CES-D). Collected data will provide a new insight of BT role and the removal of daily stress in FS management

NCT ID: NCT05793086 Recruiting - Clinical trials for Trigger Point Pain, Myofascial

Evaluation of a Novel Class of Objective Myofascial Pain Assessments

ENCOMPASS
Start date: January 27, 2023
Phase:
Study type: Observational

This is an observational study that is intended to determine the capacity of three technologies to serve as diagnostic biomarkers for myofascial pain syndrome. Investigators will seek patients with myofasical pain syndrome as well as healthy subjects for this study. Electrical impedance myography (EIM), myofiber threshold tracking (TT) excitability testing, and ultrasound with shear wave elastography (SWE) measurements will be obtained from the trapezius muscle (the muscle that extends over the back of the neck and shoulders). These measurements will be repeated within 2-5 days to assess repeatability of these methods.

NCT ID: NCT05792774 Completed - Fibromyalgia Clinical Trials

Phrenic Nerve Infiltration in Fibromyalgia

Start date: April 3, 2023
Phase: Phase 4
Study type: Interventional

It is known that nociceptive afferences in visceral pain and visceral disorders increase sensitization in subjects suffering from fibromyalgia. These patients use to present visceral comorbidities. Those comorbidities include that of peridiaphragmatic organs, which are supplied by the phrenic nerve among other innervations. It is known that peridiaphragmatic organs trigger referred pain in the neck area, via the phrenic nerves. So, the phrenic nociceptive afferences can be contributing to enhance the state of sensitization in fibromyalgia. This study aims to analyze the ability of phrenic nerve infiltration to diminish sensitization in subjects suffering fibromyalgia, by means of a randomized controlled trial.

NCT ID: NCT05792111 Recruiting - Clinical trials for Myofascial Trigger Point Pain

Caudal Epidural Steroid and Trigger Point Injection

Start date: October 12, 2022
Phase: Phase 4
Study type: Interventional

This prospective randomized study will be conducted in Bolu Abant İzzet Baysal University Hospital. Chronic low back and hip pain 72 patients aged between 18-70 years will be included in the study. The primary output of our study was NRS scores. The study of Manchikanti. L et al. (control group NRS reduction 4.4 ± 1.8; α margin of error 0.05, power 99%) (3) was taken as the basis for determining the sample size. Using the G Power 3 calculator program, 72 patients were identified to reduce their NRS scores by 25%. With a 20% exclusion rate, the total number of patients was calculated as 90